title: Sunitinib in patients with cisplatin-refractory germ cell tumors.
authors: Maria
authors: M
authors: Reckova
authors: Michal
authors: M
authors: Mego
authors: Zuzana
authors: Z
authors: Sycova-Mila
authors: Jana
authors: J
authors: Obertova
authors: Dana
authors: D
authors: Svetlovska
authors: Jozef
authors: J
authors: Mardiak
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002908:Chronic Disease; D002945:Cisplatin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007211:Indoles / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy*; D011758:Pyrroles / Q000008:administration & dosage*; D018154:Slovakia; D000077210:Sunitinib; D016896:Treatment Outcome
chemical_list: D007211:Indoles; D011758:Pyrroles; D002945:Cisplatin; D000077210:Sunitinib